NeuroMetrix promises fibromyalgia pain relief with Quell at CES
NeuroMetrix believes it has a solution that may help fibromyalgia patients fight chronic pain. At the International Consumer Electronics Show (CES), the company shared Quell, a wearable device that promises to give sufferers relief. You wear it on your upper calf and can connect it to your smartphone to keep track of progress.
Quell is a small device that attaches to your calf and can be worn during the day or night. The company claims it uses non-invasive neurostimulation technology to give people relief from chronic pain. It has been approved by the FDA and does not require a prescription. NeuroMetrix states that the wearable device is capable of stimulating the nerves, without any invasive procedures, to force the brain to release opioids. This would help people with fibromyalgia and other chronic pain conditions feel better. NeuroMetrix claims it can also benefit people who suffer from diabetes and sciatica.
Quell is not a cheap product, and the estimated cost at CES was $250. It can be connected to a smartphone for better tracking and customization. NeuroMetrix also claims it is comfortable enough to be worn during the night, but even this combination of features may not be enough to convince consumers to spend a large amount of money on a device that may or may not work.
This is not the first time that a company has tried to produce a device to fight chronic pain. Thimble Bioelectronics has the TENS patch for pain relief, and KevMed has the PainShield MD. Wearable pain relief is not a new concept, but companies continue to develop new products. There are questions about the actual benefits from the devices versus the placebo effect. However, this has not stopped people from trying the latest technology to get a break from constant pain.
Read more about fibromyalgia:
Memantine drug shows promise for fibromyalgia
Fibromyalgia study focuses on brain stimulation to fight pain
Share this content.
Please include eMaxHealth in Google Alerts to receive tomorrow's stories and SHARE this with friends if it was interesting.